[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP1223876A4 - Coiled ablation catheter system - Google Patents

Coiled ablation catheter system

Info

Publication number
EP1223876A4
EP1223876A4 EP00961755A EP00961755A EP1223876A4 EP 1223876 A4 EP1223876 A4 EP 1223876A4 EP 00961755 A EP00961755 A EP 00961755A EP 00961755 A EP00961755 A EP 00961755A EP 1223876 A4 EP1223876 A4 EP 1223876A4
Authority
EP
European Patent Office
Prior art keywords
sheath
ablating element
ablating
shape
catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00961755A
Other languages
German (de)
French (fr)
Other versions
EP1223876A1 (en
Inventor
David Keane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/396,959 external-priority patent/US6607520B2/en
Priority claimed from US09/539,056 external-priority patent/US6632223B1/en
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of EP1223876A1 publication Critical patent/EP1223876A1/en
Publication of EP1223876A4 publication Critical patent/EP1223876A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00831—Material properties
    • A61B2017/00867—Material properties shape memory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00029—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00059—Material properties
    • A61B2018/00071—Electrical conductivity
    • A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00107—Coatings on the energy applicator
    • A61B2018/00136—Coatings on the energy applicator with polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345—Vascular system
    • A61B2018/00351—Heart
    • A61B2018/00375—Ostium, e.g. ostium of pulmonary vein or artery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1435—Spiral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1497—Electrodes covering only part of the probe circumference
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/821—Ostial stents

Definitions

  • the present invention relates generally to catheter systems, and more particularly, to catheter systems for ablating and/or isolating foci that contribute to cardiac arrhythmia.
  • Catheters are commonly used in surgical procedures to access certain areas of a patient's body without resorting to invasive surgical procedures.
  • catheters are widely used in the field of cardiology to conduct electrophysiological studies in which electrical potentials within the heart are mapped to determine the cause and location of arrhythmia.
  • certain undesired conductive pathways known as foci, contribute to and cause the arrhythmia.
  • foci certain undesired conductive pathways, known as foci, contribute to and cause the arrhythmia.
  • elements on or within the catheter can be utilized to ablate or isolate the foci, thus eliminating the arrhythmia.
  • Atrial fibrillation is an uncoordinated contraction of the heart muscle within the atrium. Atrial fibrillation results from rapidly discharging foci and causes irregular heart beats, possibly leading to inefficient pumping of blood. In a significant number of patients, the foci that contribute to this condition are located within the pulmonary vein, adjacent to the atrium. These foci may be in the form of scattered groups of rapidly discharging cells. Treatment of this condition can sometimes be effective through the ablation of these foci. However, identifying the location of these foci and effecting the ablative treatment of the foci can be time consuming and difficult.
  • U.S. Patent No. 5,476,495 discloses a steerable catheter system that is able to conduct cardiac mapping and ablation.
  • U.S. Patent No. 5,507,743 discloses a radio frequency (RF) treatment apparatus that includes a RF electrode that assumes a helical orientation upon deployment.
  • U.S. Patent No. 5,738,683 discloses a cardiac mapping/ablation catheter that includes an electrode that may be deployed in the shape of a loop.
  • U.S. Patent No. 5,782,879 discloses an endocardial mapping and ablation system in which the catheter includes a deploy able distal extremity, in the form of a cage-like member that includes a plurality of electrodes.
  • the present invention provides a cardiac catheter system for ablating tissue to electrically isolate certain tissue from arrhythmia-inducing foci.
  • the invention is primarily shown and described as a cardiac catheter system for ablating tissue with RF energy, it is understood that the system has other applications and embodiments as well.
  • other types of energy such as microwave, laser, cryogenic, and ultrasonic energy, can be used without departing from the scope of the invention.
  • a cardiac ablation catheter system in one embodiment, includes an elongate, flexible sheath having an internal lumen and an open distal end.
  • An ablating element is disposed within the sheath and is selectively deployable therefrom so as to project from the sheath in a substantially coil-like shape.
  • the deployed ablating element has a geometry forming at least one revolution for generating a circumferential lesion within a vessel, such as a pulmonary vein.
  • the ablating element is oriented in a plane that is substantially orthogonal to the longitudinal axis of the sheath in the deployed position to facilitate the formation of a lesion about the vein inner wall circumference.
  • the catheter system can include a variety of mechanisms for deploying the ablation member from the catheter.
  • the ablation member is released from a distal end of the catheter such that it assumes a predetermined shape.
  • the catheter includes a hatch or port from which the ablation member is selectively deployed.
  • the elongate member includes a distal end affixed to a support member that is extendable from the catheter distal end. By rotating and/or longitudinally displacing the support member, the ablation member can be deployed such it assumes a desired size.
  • the catheter is manipulated through the arterial network until the catheter is located proximate the desired treatment site.
  • the treatment site may be a location within the pulmonary vein or left atrium at or near the pulmonary vein os or in the right ventricular outflow tract, such as at the junction of the right atrium and superior vena cava.
  • the ablating element is then deployed from the catheter such that the coil-like ablating element is generally oriented in a plane orthogonal to the longitudinal axis of the sheath.
  • the deployed ablating element should be in contact with tissue about the circumference of the vein inner wall, such as at the os.
  • the ablation element is then energized to ablate the target tissue to electrically isolate the foci from healthy tissue on the opposite side of the formed lesion.
  • the atria for example, can be electrically isolated from a treated pulmonary vein by creating a circumferential lesion on the inner wall of the left atrium or in the pulmonary vein proximate the os.
  • FIG. 1 is a perspective view of an ablation catheter system in accordance with the present invention
  • FIG. 2 is a side view of a portion of the catheter system of FIG. 1;
  • FIG. 3 is a front view of a portion of the catheter system of FIG. 1;
  • FIG. 4 is a pictorial representation of the orientation of an ablating element in a deployed position and a catheter that forms a part of the catheter system of FIG. 1 ;
  • FIG. 5 is a perspective view of an alternative geometry for an ablating element
  • FIG. 6 is a perspective view of a further embodiment of an ablation catheter system in accordance with the present invention
  • FIG. 7 is a perspective view of another embodiment of an ablation catheter in accordance with the present invention.
  • FIG. 7 A is a pictorial representation of an alternative embodiment of an ablation catheter in accordance with the present invention
  • FIG. 8A is a pictorial representation of a further embodiment of an ablation catheter in accordance with the present invention shown in a first position
  • FIG. 8B is a pictorial representation of the catheter of FIG. 8A shown in a second position
  • FIG. 8C is a pictorial representation of the catheter system of FIG. 8A shown in a a third position.
  • FIG. 9 is a perspective view of another embodiment of an ablation catheter system in accordance with the present invention.
  • FIGS. 1-3 show an ablation catheter system 100 in accordance with the present invention having an ablation element 102 that is deployable from a flexible elongate catheter or sheath 104.
  • the catheter sheath 104 should be semi-rigid and flexible so as to be readily steerable to a desired location in a patient's body, such as proximate the os of a pulmonary vein.
  • catheter delivery systems are well known to those of ordinary skill in the art.
  • the deployed coil-like ablation element 102 has a shape that includes one or more revolutions substantially oriented in a transverse plane 106 (FIG. 4) that is orthogonal to a longitudinal axis 108 of the sheath 104.
  • This geometry facilitates treating tissue about a circumference of a vessel, such as a pulmonary vein.
  • the circumferential region of ablated tissue electrically isolates tissue on opposite sides of the ablated tissue.
  • the atria for example, can be electrically isolated from any arrhythmia-inducing foci within the pulmonary vein.
  • the catheter system 100 includes a tubular inner member 110 for housing the ablation member 102 in the non-deployed position.
  • the inner member 102 be formed from an insulative material to prevent unintended contact with tissue, for example.
  • Exemplary materials for the insulative inner member 110 include Teflon and polyethylene.
  • the elongate ablation element 102 can have a variety of geometries that are effective to form a generally annular lesion about a circumference of a vessel wall. Exemplary geometries include annular shapes having one or more revolutions, crenulated, corrugated, and combinations thereof. It is understood that the term “revolution” should be construed broadly to include configurations of somewhat less than three hundred and sixty degrees. It is further understood that the transverse plane 106 on which the revolutions of the elongate member are located provides a general frame of reference and that the elongate member can vary in distance from the plane as the elongate member forms a revolution.
  • the ablation member 102 has a coil-like appearance that forms approximately one revolution generally oriented in the transverse plane 106 that is substantially orthogonal to a longitudinal axis 108 of the sheath.
  • This configuration is well-suited for contacting a vessel inner wall about its circumference or for contacting the posterior wall of the left atrium to circumscribe the os of a pulmonary vein.
  • the resultant circumferential lesion on the atrial or vessel wall can be effective to isolate electrical impulses from the offending foci from passing to healthy tissue on the opposite side of the lesion.
  • FIG. 5 shows the catheter system 100' including an ablation member 102' having an alternative, crenulated geometry. That is, the ablation member 102' undulates so as to intersect the transverse plane 106' at defined intervals along a revolution. This configuration may inhibit or limit stenosis of the treated vessel proximate the circumferential lesion.
  • the ablation member 102' can be partly surrounded by an insulative coating 112.
  • the ablation member 102 is formed from a conductive elastic or superelastic shape memory material for ablating tissue with RF energy.
  • shape memory materials include nickel-titanium alloys, such as Nitinol, and copper based alloys. It is understood that shape memory materials, in general, can be plastically deformed from a first shape at a relatively low temperature. Upon heating the material to some higher temperature, such as by resistive heating, the material will tend to return to the first shape. Such materials can have so-called one-way and two- way shape memories.
  • the ablation member can be at least partly surrounded by an insulative coating. The insulative coating can be disposed on the ablation member so as to form a plurality of discrete electrodes for ablating tissue at selected locations along the vessel circumference.
  • the ablation element can be deployed from the sheath using a variety of mechanisms that are compatible with steerable catheter systems.
  • Exemplary mechanisms include predetermined shapes for the elongate member, manual deployment mechanisms, and guide-wire based mechanisms.
  • FIG. 6 shows an ablation catheter system 200 having an ablation member 202 with a distal end 204 secured to a bulbous end 206 of a support member 208.
  • the support member 208 is disposed within the sheath 210 and connected to an actuator (not shown) at a proximal end of the catheter.
  • the support member 208 is longitudinally displaced with respect to the sheath such that the bulbous end 206 protrudes from the end 212 of the catheter.
  • the ablation member 202 Upon exiting the sheath 210, the ablation member 202 assumes a predetermined shape that includes about one revolution in a transverse plane 214 orthogonal to the sheath longitudinal axis 216.
  • the ablation member 202 can extend from a retractable support wire 218.
  • the bulbous end 206 of the support member is radiopaque to facilitate determining the ablation member position on an external viewing system, such as an X-ray system.
  • the ablation member 202 can be wound on the support member
  • the support member 208 can be rotated in a predetermined direction such that the ablation member 202 is unwound or released from the support member. The support member 208 can be rotated until the ablation member extends from the support member a desired distance. After ablation, the ablation member 202 can be retracted to the non-deployed state by rotating the support member in the opposite direction.
  • FIG. 7 shows an ablation catheter system 300 including a guide wire 302 for manipulating a catheter 304 within the patient's body.
  • the guide wire 302 can be utilized in conjunction with mapping systems (which may be separate from or integral with the catheter system 300) to locate arrhythmic foci.
  • the catheter 304 includes a hatch 306 from which an ablation member 308 can be deployed. Upon actuating the hatch 306 to the open position, the ablation member 308 discharges from the resultant opening 310 and assumes a predetermined configuration. It is understood that the predetermined annular shape will be effective to contact vessel walls having a circumference less than or equal to a predetermined value, which by way of example, may be in the range of about 0.4 centimeters to about 4.0 centimeters.
  • FIG. 7 A shows an alternative embodiment of a catheter system 350 including an ablation member 352 having an exposed proximal portion 354 for ablating tissue and an insulated distal portion 356 for centering the catheter within a pulmonary vein 358.
  • the catheter system 350 is well suited for creating a circumferential lesion on the posterior left atrial wall 360 around the pulmonary vein os 362.
  • FIGS. 8A-C show a manually expandable ablation member 402 that forms a part of a cardiac ablation catheter system 400 in accordance with the present invention.
  • the system 400 includes a guide-wire based catheter 404 with an ablation member 406 that is manually deployable from the catheter.
  • the ablation member 406 is coupled to a semi-rigid support member 408 (FIG. 8C) that can be rotated and/or longitudinally displaced so as to deploy the ablation member 4026.
  • the size of the loop formed by the ablation member 406 can be selected by controlling the amount of rotation/displacement of the support member 408.
  • the leading end of the ablation element can be affixed to the guide wire.
  • the ablating element can be manipulated by rotating the guide wire.
  • FIG. 9 shows a further embodiment of a guide-wire based ablation catheter system 500 having a manually deployable ablation member 502.
  • This system is similar to the system 200 shown in FIG 6 with the addition of a guide wire 504 that can provide additional stability during ablation.
  • the catheter 506 is mounted on the guide wire 504 to facilitate advancement of the catheter into the pulmonary vein.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plasma & Fusion (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgical Instruments (AREA)
  • Electrotherapy Devices (AREA)

Abstract

A cardiac ablation catheter (100) includes a coil-like ablating element (102) that is deployed from an elongate, flexible sheath (104). The ablating element (102), while in the deployed position, has a shape with at least one revolution oriented in a plane that is orthogonal to a longitudinal axis (108) of the sheath. The catheter system (100) is well-suited to ablate a circumferential region of tissue about a pulmonary vein or the posterior wall of the left atrium proximate the pulmonary vein os. The treated tissue region electrically isolates the atria from the pulmonary vein.

Description

COILED ABLATION CATHETER SYSTEM
FIELD OF THE INVENTION
The present invention relates generally to catheter systems, and more particularly, to catheter systems for ablating and/or isolating foci that contribute to cardiac arrhythmia.
BACKGROUND OF THE INVENTION
Catheters are commonly used in surgical procedures to access certain areas of a patient's body without resorting to invasive surgical procedures. For example, catheters are widely used in the field of cardiology to conduct electrophysiological studies in which electrical potentials within the heart are mapped to determine the cause and location of arrhythmia. In many cases, certain undesired conductive pathways, known as foci, contribute to and cause the arrhythmia. Once the location of foci is identified, elements on or within the catheter can be utilized to ablate or isolate the foci, thus eliminating the arrhythmia.
One form of arrhythmia is atrial fibrillation, which is an uncoordinated contraction of the heart muscle within the atrium. Atrial fibrillation results from rapidly discharging foci and causes irregular heart beats, possibly leading to inefficient pumping of blood. In a significant number of patients, the foci that contribute to this condition are located within the pulmonary vein, adjacent to the atrium. These foci may be in the form of scattered groups of rapidly discharging cells. Treatment of this condition can sometimes be effective through the ablation of these foci. However, identifying the location of these foci and effecting the ablative treatment of the foci can be time consuming and difficult.
A variety of cardiac mapping and ablation catheter systems are well known in the art. For example, U.S. Patent No. 5,476,495 (Kordis et al.) discloses a steerable catheter system that is able to conduct cardiac mapping and ablation. U.S. Patent No. 5,507,743 (Edwards et al.) discloses a radio frequency (RF) treatment apparatus that includes a RF electrode that assumes a helical orientation upon deployment. U.S. Patent No. 5,738,683 (Osypka) discloses a cardiac mapping/ablation catheter that includes an electrode that may be deployed in the shape of a loop. U.S. Patent No. 5,782,879 (Imran) discloses an endocardial mapping and ablation system in which the catheter includes a deploy able distal extremity, in the form of a cage-like member that includes a plurality of electrodes.
Despite the existence of these references and existing ablation catheter systems, there exists a need to provide a system that is able to effectively treat atrial fibrillation conditions that are caused by foci present within the pulmonary vein.
SUMMARY OF THE INVENTION
The present invention provides a cardiac catheter system for ablating tissue to electrically isolate certain tissue from arrhythmia-inducing foci. Although the invention is primarily shown and described as a cardiac catheter system for ablating tissue with RF energy, it is understood that the system has other applications and embodiments as well. For example, other types of energy, such as microwave, laser, cryogenic, and ultrasonic energy, can be used without departing from the scope of the invention.
In one embodiment, a cardiac ablation catheter system includes an elongate, flexible sheath having an internal lumen and an open distal end. An ablating element is disposed within the sheath and is selectively deployable therefrom so as to project from the sheath in a substantially coil-like shape. In an exemplary embodiment, the deployed ablating element has a geometry forming at least one revolution for generating a circumferential lesion within a vessel, such as a pulmonary vein. In general, the ablating element is oriented in a plane that is substantially orthogonal to the longitudinal axis of the sheath in the deployed position to facilitate the formation of a lesion about the vein inner wall circumference.
The catheter system can include a variety of mechanisms for deploying the ablation member from the catheter. In one embodiment, the ablation member is released from a distal end of the catheter such that it assumes a predetermined shape. In another embodiment, the catheter includes a hatch or port from which the ablation member is selectively deployed. In a further embodiment, the elongate member includes a distal end affixed to a support member that is extendable from the catheter distal end. By rotating and/or longitudinally displacing the support member, the ablation member can be deployed such it assumes a desired size.
To ablate or isolate the target foci tissue, the catheter is manipulated through the arterial network until the catheter is located proximate the desired treatment site. For example, the treatment site may be a location within the pulmonary vein or left atrium at or near the pulmonary vein os or in the right ventricular outflow tract, such as at the junction of the right atrium and superior vena cava. The ablating element is then deployed from the catheter such that the coil-like ablating element is generally oriented in a plane orthogonal to the longitudinal axis of the sheath. The deployed ablating element should be in contact with tissue about the circumference of the vein inner wall, such as at the os. The ablation element is then energized to ablate the target tissue to electrically isolate the foci from healthy tissue on the opposite side of the formed lesion. The atria, for example, can be electrically isolated from a treated pulmonary vein by creating a circumferential lesion on the inner wall of the left atrium or in the pulmonary vein proximate the os.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
FIG. 1 is a perspective view of an ablation catheter system in accordance with the present invention;
FIG. 2 is a side view of a portion of the catheter system of FIG. 1; FIG. 3 is a front view of a portion of the catheter system of FIG. 1; FIG. 4 is a pictorial representation of the orientation of an ablating element in a deployed position and a catheter that forms a part of the catheter system of FIG. 1 ;
FIG. 5 is a perspective view of an alternative geometry for an ablating element; FIG. 6 is a perspective view of a further embodiment of an ablation catheter system in accordance with the present invention; FIG. 7 is a perspective view of another embodiment of an ablation catheter in accordance with the present invention;
FIG. 7 A is a pictorial representation of an alternative embodiment of an ablation catheter in accordance with the present invention; FIG. 8A is a pictorial representation of a further embodiment of an ablation catheter in accordance with the present invention shown in a first position;
FIG. 8B is a pictorial representation of the catheter of FIG. 8A shown in a second position;
FIG. 8C is a pictorial representation of the catheter system of FIG. 8A shown in a a third position; and
FIG. 9 is a perspective view of another embodiment of an ablation catheter system in accordance with the present invention.
DETAILED DESCRIPTION OF THE INVENTION FIGS. 1-3 show an ablation catheter system 100 in accordance with the present invention having an ablation element 102 that is deployable from a flexible elongate catheter or sheath 104. The catheter sheath 104 should be semi-rigid and flexible so as to be readily steerable to a desired location in a patient's body, such as proximate the os of a pulmonary vein. Such catheter delivery systems are well known to those of ordinary skill in the art. In general, the deployed coil-like ablation element 102 has a shape that includes one or more revolutions substantially oriented in a transverse plane 106 (FIG. 4) that is orthogonal to a longitudinal axis 108 of the sheath 104. This geometry facilitates treating tissue about a circumference of a vessel, such as a pulmonary vein. The circumferential region of ablated tissue electrically isolates tissue on opposite sides of the ablated tissue. Thus, the atria, for example, can be electrically isolated from any arrhythmia-inducing foci within the pulmonary vein.
In one embodiment, the catheter system 100 includes a tubular inner member 110 for housing the ablation member 102 in the non-deployed position. In general, it is preferred that the inner member 102 be formed from an insulative material to prevent unintended contact with tissue, for example. Exemplary materials for the insulative inner member 110 include Teflon and polyethylene.
The elongate ablation element 102 can have a variety of geometries that are effective to form a generally annular lesion about a circumference of a vessel wall. Exemplary geometries include annular shapes having one or more revolutions, crenulated, corrugated, and combinations thereof. It is understood that the term "revolution" should be construed broadly to include configurations of somewhat less than three hundred and sixty degrees. It is further understood that the transverse plane 106 on which the revolutions of the elongate member are located provides a general frame of reference and that the elongate member can vary in distance from the plane as the elongate member forms a revolution.
In the exemplary embodiment of FIGS. 1-3, which shows the ablation member 102 in the deployed state, the ablation member 102 has a coil-like appearance that forms approximately one revolution generally oriented in the transverse plane 106 that is substantially orthogonal to a longitudinal axis 108 of the sheath. This configuration is well-suited for contacting a vessel inner wall about its circumference or for contacting the posterior wall of the left atrium to circumscribe the os of a pulmonary vein. The resultant circumferential lesion on the atrial or vessel wall can be effective to isolate electrical impulses from the offending foci from passing to healthy tissue on the opposite side of the lesion.
FIG. 5 shows the catheter system 100' including an ablation member 102' having an alternative, crenulated geometry. That is, the ablation member 102' undulates so as to intersect the transverse plane 106' at defined intervals along a revolution. This configuration may inhibit or limit stenosis of the treated vessel proximate the circumferential lesion. The ablation member 102' can be partly surrounded by an insulative coating 112.
In one embodiment, the ablation member 102 is formed from a conductive elastic or superelastic shape memory material for ablating tissue with RF energy. Exemplary shape memory materials include nickel-titanium alloys, such as Nitinol, and copper based alloys. It is understood that shape memory materials, in general, can be plastically deformed from a first shape at a relatively low temperature. Upon heating the material to some higher temperature, such as by resistive heating, the material will tend to return to the first shape. Such materials can have so-called one-way and two- way shape memories. In further embodiments (not shown), the ablation member can be at least partly surrounded by an insulative coating. The insulative coating can be disposed on the ablation member so as to form a plurality of discrete electrodes for ablating tissue at selected locations along the vessel circumference.
The ablation element can be deployed from the sheath using a variety of mechanisms that are compatible with steerable catheter systems. Exemplary mechanisms include predetermined shapes for the elongate member, manual deployment mechanisms, and guide-wire based mechanisms.
FIG. 6 shows an ablation catheter system 200 having an ablation member 202 with a distal end 204 secured to a bulbous end 206 of a support member 208. The support member 208 is disposed within the sheath 210 and connected to an actuator (not shown) at a proximal end of the catheter. To deploy the ablation member 202, the support member 208 is longitudinally displaced with respect to the sheath such that the bulbous end 206 protrudes from the end 212 of the catheter. Upon exiting the sheath 210, the ablation member 202 assumes a predetermined shape that includes about one revolution in a transverse plane 214 orthogonal to the sheath longitudinal axis 216. The ablation member 202 can extend from a retractable support wire 218.
In one embodiment, the bulbous end 206 of the support member is radiopaque to facilitate determining the ablation member position on an external viewing system, such as an X-ray system. Alternatively, the ablation member 202 can be wound on the support member
208 in the non-deployed state. The support member 208 can be rotated in a predetermined direction such that the ablation member 202 is unwound or released from the support member. The support member 208 can be rotated until the ablation member extends from the support member a desired distance. After ablation, the ablation member 202 can be retracted to the non-deployed state by rotating the support member in the opposite direction.
FIG. 7 shows an ablation catheter system 300 including a guide wire 302 for manipulating a catheter 304 within the patient's body. It is understood that the guide wire 302 can be utilized in conjunction with mapping systems (which may be separate from or integral with the catheter system 300) to locate arrhythmic foci. The catheter 304 includes a hatch 306 from which an ablation member 308 can be deployed. Upon actuating the hatch 306 to the open position, the ablation member 308 discharges from the resultant opening 310 and assumes a predetermined configuration. It is understood that the predetermined annular shape will be effective to contact vessel walls having a circumference less than or equal to a predetermined value, which by way of example, may be in the range of about 0.4 centimeters to about 4.0 centimeters.
FIG. 7 A shows an alternative embodiment of a catheter system 350 including an ablation member 352 having an exposed proximal portion 354 for ablating tissue and an insulated distal portion 356 for centering the catheter within a pulmonary vein 358.
The catheter system 350 is well suited for creating a circumferential lesion on the posterior left atrial wall 360 around the pulmonary vein os 362.
FIGS. 8A-C show a manually expandable ablation member 402 that forms a part of a cardiac ablation catheter system 400 in accordance with the present invention. The system 400 includes a guide-wire based catheter 404 with an ablation member 406 that is manually deployable from the catheter. In one embodiment, the ablation member 406 is coupled to a semi-rigid support member 408 (FIG. 8C) that can be rotated and/or longitudinally displaced so as to deploy the ablation member 4026. The size of the loop formed by the ablation member 406 can be selected by controlling the amount of rotation/displacement of the support member 408. Alternatively, the leading end of the ablation element can be affixed to the guide wire. In one embodiment, the ablating element can be manipulated by rotating the guide wire.
FIG. 9 shows a further embodiment of a guide-wire based ablation catheter system 500 having a manually deployable ablation member 502. This system is similar to the system 200 shown in FIG 6 with the addition of a guide wire 504 that can provide additional stability during ablation. The catheter 506 is mounted on the guide wire 504 to facilitate advancement of the catheter into the pulmonary vein.
One skilled in the art will appreciate further features and advantages of the invention based on the above-described embodiments. Accordingly, the invention is not to be limited by what has been particularly shown and described, except as indicated by the appended claims. All publications and references cited herein are expressly incorporated herein by reference in their entirety.
What is claimed is:

Claims

1. A cardiac catheter system, comprising: an elongate, flexible sheath having an internal lumen, a distal end and a longitudinal axis; an ablating element disposed within the sheath and selectively deployable therefrom so as to project from the sheath in a substantially coil-like shape having at least one revolution, wherein the ablating element, in a deployed condition, is oriented in a plane that is substantially orthogonal to the longitudinal axis of the sheath; and at least one exposed, conductive region disposed on at least a portion of the ablating element.
2. The system of claim 1, wherein the ablating element is self-expanding and assumes a predetermined shape upon deployment from the sheath.
3. The system of claim 2, wherein the ablating element is made from a shape-memory material.
4. The system of claim 3 wherein the shape-memory material is selected from the group consisting of nickel-titanium alloys and copper-based alloys.
5. The system of claim 3 wherein the shape-memory material is superelastic.
6. The system of claim 3, wherein the shape-memory material has a two-way shape memory.
7. The system of claim 1 wherein the ablating element further comprises a terminal which is connectable to an energy source selected from the group consisting of radio frequency energy, laser energy, microwave energy, ultrasonic energy, and cryogenic energy.
8. The system of claim 1, further comprising a guide wire disposed within and selectively deployable from the sheath.
9. The system of claim 8, wherein a leading end of the ablating element is secured to the guide wire.
10. The system of claim 9, wherein the ablating element is manually and selectively expandable from the sheath.
11. The system of claim 1 wherein the coil-like shape has a radius which expands as the ablating element advances from the sheath.
12. The system of claim 9 wherein the ablating element is expandable from the sheath by rotating the guide wire along the longitudinal axis of the sheath.
13. The system of claim 9, wherein the leading end of the ablating element is surrounded by an insulating material.
14. The system of claim 9, wherein a lagging end of the ablating element supports the coil-like shape of the ablating element.
15. The system of claim 1, further comprising a non-conductive, insulating element disposed within the sheath and selectively deployable therefrom, wherein the ablating element is deployable from within the non-conducting, insulating element.
16. The system of claim 15 wherein the ablating element is retractable into the non- conductive, insulating element.
17. The system of claim 1, wherein the at least one exposed, conductive region further comprises a plurality of discrete electrodes.
18. The system of claim 1, wherein the coil-like shape of the ablating member has a crenulated circumferential region.
19. A cardiac catheter system, comprising an elongate, flexible sheath having dimensions suitable for intravascular passage and a longitudinal axis; a guide wire disposed within the sheath and selectively deployable from a distal end of the sheath; an ablating element disposed within and selectively deployable from the distal end of the sheath in concert with the guide wire, the ablating element having a leading end secured to the guide wire and a trailing portion disposed within the sheath; and an ablating element deployment mechanism that is effective to advance at least a portion of the trailing portion of the ablating element out of the distal end of the sheath by a predetermined distance to cause the ablating element to assume a coil-like shape.
20. A method for ablating a selected region of body tissue, comprising the steps of:
(a) inserting a catheter into a body, the catheter comprising: an elongate, flexible sheath having an internal lumen, an open distal end and a longitudinal axis; an ablating element disposed within the sheath and selectively deployable therefrom so as to project from the sheath in a substantially coil-like shape having at least one revolution, wherein the ablating element, in a deployed condition, is oriented in a plane that is substantially orthogonal to the longitudinal axis of the sheath; and at least one exposed, conductive region disposed on at least a portion of the ablating element;
(b) advancing the ablating element distally out of the sheath to allow the ablating element to form a substantially coil-like shape having at least one revolution;
(c) contacting the conductive region of the ablating element with a selected region of body tissue; and (d) transmitting ablating energy to the ablating element while contacting the selected region of body tissue.
21. The method of claim 20, wherein the selected region of body tissue is located on a posterior wall of the left atrium proximate the os of a pulmonary vein.
22. The method of claim 20, wherein the selected region of body tissue is located on an inner wall of a bodily lumen.
EP00961755A 1999-09-15 2000-09-11 Coiled ablation catheter system Withdrawn EP1223876A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/396,959 US6607520B2 (en) 1999-09-15 1999-09-15 Coiled ablation catheter system
US09/539,056 US6632223B1 (en) 2000-03-30 2000-03-30 Pulmonary vein ablation stent and method
US539056 2000-03-30
PCT/US2000/024836 WO2001019270A1 (en) 1999-09-15 2000-09-11 Coiled ablation catheter system
US396959 2003-03-25

Publications (2)

Publication Number Publication Date
EP1223876A1 EP1223876A1 (en) 2002-07-24
EP1223876A4 true EP1223876A4 (en) 2003-05-02

Family

ID=27015709

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00961755A Withdrawn EP1223876A4 (en) 1999-09-15 2000-09-11 Coiled ablation catheter system

Country Status (4)

Country Link
EP (1) EP1223876A4 (en)
JP (1) JP2003522561A (en)
CA (2) CA2638963C (en)
WO (2) WO2001019269A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890329B2 (en) 1999-06-15 2005-05-10 Cryocath Technologies Inc. Defined deflection structure
JP2004533890A (en) 2001-07-06 2004-11-11 トリカーディア，エル．エル．シー． Antiarrhythmic device and method of using same
DE10152066A1 (en) * 2001-10-25 2003-05-08 Curative Ag stent
US6656175B2 (en) * 2001-12-11 2003-12-02 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US6814733B2 (en) * 2002-01-31 2004-11-09 Biosense, Inc. Radio frequency pulmonary vein isolation
DE10218426A1 (en) * 2002-04-24 2003-11-06 Biotronik Mess & Therapieg Ablation device for cardiac tissue, in particular for producing linear lesions between two vascular orifices in the heart
US20040106952A1 (en) * 2002-12-03 2004-06-03 Lafontaine Daniel M. Treating arrhythmias by altering properties of tissue
EP1605875A3 (en) 2003-03-03 2005-12-28 Sinus Rhythm Technologies, Inc. Electrical block positioning devices and methods of use therefor
US20040220655A1 (en) 2003-03-03 2004-11-04 Sinus Rhythm Technologies, Inc. Electrical conduction block implant device
US7266414B2 (en) 2003-10-24 2007-09-04 Syntach, Ag Methods and devices for creating electrical block at specific sites in cardiac tissue with targeted tissue ablation
SE526861C2 (en) 2003-11-17 2005-11-15 Syntach Ag Tissue lesion creation device and a set of devices for the treatment of cardiac arrhythmia disorders
US9398967B2 (en) 2004-03-02 2016-07-26 Syntach Ag Electrical conduction block implant device
US20050222672A1 (en) * 2004-04-01 2005-10-06 Cappella, Inc. Ostial stent
US7993334B2 (en) * 2005-12-29 2011-08-09 Boston Scientific Scimed, Inc. Low-profile, expanding single needle ablation probe
CA2735240A1 (en) * 2008-10-04 2010-04-08 Boston Scientific Scimed, Inc. Loop structures for supporting diagnostic and/or therapeutic elements in contact with tissue
US8712550B2 (en) 2008-12-30 2014-04-29 Biosense Webster, Inc. Catheter with multiple electrode assemblies for use at or near tubular regions of the heart
US10166067B2 (en) * 2009-02-12 2019-01-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter and method for electically isolating cardiac tissue
EP2747690B1 (en) * 2011-08-24 2019-01-23 Boston Scientific Scimed, Inc. Device and methods for nerve modulation
US9179974B2 (en) * 2013-03-15 2015-11-10 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
US10610292B2 (en) 2014-04-25 2020-04-07 Medtronic Ardian Luxembourg S.A.R.L. Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology
US9468407B2 (en) 2014-05-30 2016-10-18 Biosense Webster (Israel) Ltd. Catheter with distal section having side-by-side loops
PL3146924T3 (en) 2015-09-24 2023-03-20 Medinice S.A. Cryoapplicator for minimally invasive surgical cardiac ablation
US12082917B2 (en) 2018-01-24 2024-09-10 Medtronic Ireland Manufacturing Unlimited Company Systems, devices, and methods for assessing efficacy of renal neuromodulation therapy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279299A (en) * 1991-02-15 1994-01-18 Cardiac Pathways Corporation Endocardial mapping and ablation system and catheter probe
EP0626153A1 (en) * 1993-05-28 1994-11-30 Medical Shape Memory, Ltd. Ni-Ti medical stent
US5582609A (en) * 1993-10-14 1996-12-10 Ep Technologies, Inc. Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US5738683A (en) * 1994-07-16 1998-04-14 Osypka; Peter Mapping and ablation catheter

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476495A (en) * 1993-03-16 1995-12-19 Ep Technologies, Inc. Cardiac mapping and ablation systems
DE69434664T2 (en) * 1993-10-14 2006-11-09 Boston Scientific Ltd., Barbados ELECTRODES FOR GENERATING SPECIFIC PATTERNS OF PATHOLOGICALLY MODIFIED TISSUE
US5507743A (en) * 1993-11-08 1996-04-16 Zomed International Coiled RF electrode treatment apparatus
US5573531A (en) * 1994-06-20 1996-11-12 Gregory; Kenton W. Fluid core laser angioscope
US5593405A (en) * 1994-07-16 1997-01-14 Osypka; Peter Fiber optic endoscope
US5836940A (en) * 1994-10-25 1998-11-17 Latis, Inc. Photoacoustic drug delivery
US6012457A (en) * 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
DE69801512T2 (en) * 1997-10-30 2002-05-29 Boston Scientific Ltd., Saint Michael DISTAL UNIT OF A CATHETER WITH TOW WIRE
US6120500A (en) * 1997-11-12 2000-09-19 Daig Corporation Rail catheter ablation and mapping system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279299A (en) * 1991-02-15 1994-01-18 Cardiac Pathways Corporation Endocardial mapping and ablation system and catheter probe
EP0626153A1 (en) * 1993-05-28 1994-11-30 Medical Shape Memory, Ltd. Ni-Ti medical stent
US5582609A (en) * 1993-10-14 1996-12-10 Ep Technologies, Inc. Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US5738683A (en) * 1994-07-16 1998-04-14 Osypka; Peter Mapping and ablation catheter

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0119270A1 *

Also Published As

Publication number Publication date
WO2001019270A1 (en) 2001-03-22
JP2003522561A (en) 2003-07-29
CA2638963C (en) 2012-03-20
CA2638963A1 (en) 2001-03-22
WO2001019269A1 (en) 2001-03-22
CA2388823C (en) 2008-11-18
EP1223876A1 (en) 2002-07-24
CA2388823A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
US6960206B2 (en) Coiled ablation catheter system
CA2638963C (en) Coiled ablation catheter system
US6972016B2 (en) Helically shaped electrophysiology catheter
EP2229905B1 (en) An ablation catheter
CA2321413C (en) Radio-frequency based catheter system and hollow co-axial cable for ablation of body tissues
US6711444B2 (en) Methods of deploying helical diagnostic and therapeutic element supporting structures within the body
US6917834B2 (en) Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates
EP2568921A2 (en) Method and device for treatment of arrhythmias and other maladies
WO2010088301A1 (en) Catheters and methods for performing electrophysiological interventions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020415

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61B 18/14 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030318

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61F 2/06 B

Ipc: 7A 61B 18/14 A

17Q First examination report despatched

Effective date: 20040622

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050730